ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 137 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,023,000 | -0.8% | 19,135 | -23.5% | 0.13% | -14.2% |
Q3 2020 | $1,031,000 | -19.1% | 25,000 | -68.3% | 0.15% | +48.0% |
Q4 2018 | $1,274,000 | +53.3% | 78,752 | +96.7% | 0.10% | +2.0% |
Q3 2018 | $831,000 | +56.8% | 40,032 | +140.5% | 0.10% | +15.3% |
Q3 2016 | $530,000 | -1.9% | 16,647 | 0.0% | 0.08% | -5.6% |
Q2 2016 | $540,000 | +16.1% | 16,647 | 0.0% | 0.09% | +12.5% |
Q1 2016 | $465,000 | -21.6% | 16,647 | 0.0% | 0.08% | -14.0% |
Q4 2015 | $593,000 | +7.6% | 16,647 | 0.0% | 0.09% | +3.3% |
Q3 2015 | $551,000 | -20.9% | 16,647 | 0.0% | 0.09% | -14.3% |
Q2 2015 | $697,000 | +28.4% | 16,647 | 0.0% | 0.10% | +38.2% |
Q1 2015 | $543,000 | +2.6% | 16,647 | 0.0% | 0.08% | -1.3% |
Q4 2014 | $529,000 | +28.4% | 16,647 | 0.0% | 0.08% | +22.2% |
Q3 2014 | $412,000 | +9.6% | 16,647 | 0.0% | 0.06% | +14.5% |
Q2 2014 | $376,000 | -7.2% | 16,647 | 0.0% | 0.06% | -6.8% |
Q1 2014 | $405,000 | -2.6% | 16,647 | 0.0% | 0.06% | 0.0% |
Q4 2013 | $416,000 | -9.0% | 16,647 | 0.0% | 0.06% | -14.5% |
Q3 2013 | $457,000 | +51.3% | 16,647 | 0.0% | 0.07% | +30.2% |
Q2 2013 | $302,000 | – | 16,647 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |